Sees turnover increasing 12%-13%, up from the previous view of 8%-10%, with adjusted operating profit growth of 13%-15%, up from the prior view of 11%-13%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on GSK:
- GSK, Arrowhead announce deal with Janssen for rights to JNJ-3989
- 23andMe enters collaboration extension with data licensing agreement with GSK
- GSK reports Phase III RUBY trial of Jemperli plus chemo meets OS endpoint
- GSK Earnings this Week: How Will it Perform?
- Alector achieves target enrollment in INFRONT-3 Phase 3 trial of latozinemab